This week we have updates for you from the FDA for approval of Pemazyre for the treatment of cholangiocarcinoma and new indications approved for Imbruvica and Trodelvy. We'll also be giving an update on the coronavirus epidemic and flu season to date. Don't forget to like, share, and subscribe! Enjoy!